These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24588302)

  • 1. Podoplanin expression in cancer-associated fibroblasts predicts aggressive behavior in melanoma.
    Kan S; Konishi E; Arita T; Ikemoto C; Takenaka H; Yanagisawa A; Katoh N; Asai J
    J Cutan Pathol; 2014 Jul; 41(7):561-7. PubMed ID: 24588302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recruitment of podoplanin positive cancer-associated fibroblasts in metastatic lymph nodes predicts poor prognosis in pathological N2 stage III lung adenocarcinoma.
    Neri S; Ishii G; Taira T; Hishida T; Yoshida J; Nishimura M; Nagai K; Ochiai A
    Ann Surg Oncol; 2012 Nov; 19(12):3953-62. PubMed ID: 22669451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The protein expression of TRP-1 and galectin-1 in cutaneous malignant melanomas.
    Bolander A; Agnarsdóttir M; Strömberg S; Ponten F; Hesselius P; Uhlen M; Bergqvist M
    Cancer Genomics Proteomics; 2008; 5(6):293-300. PubMed ID: 19287070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
    Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
    Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of isolated HMB45 or Melan A positive cells in Melanoma sentinel lymph nodes.
    Satzger I; Völker B; Meier A; Schenck F; Kapp A; Gutzmer R
    Am J Surg Pathol; 2007 Aug; 31(8):1175-80. PubMed ID: 17667539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
    Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
    J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podoplanin expression in cutaneous head and neck squamous cell carcinoma--prognostic value and clinicopathologic implications.
    Kreppel M; Krakowezki A; Kreppel B; Drebber U; Wedemeyer I; Mauch C; Zöller JE; Scheer M
    J Surg Oncol; 2013 Mar; 107(4):376-83. PubMed ID: 22886751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Podoplanin-expressing cancer-associated fibroblasts are associated with poor prognosis in invasive breast cancer.
    Schoppmann SF; Berghoff A; Dinhof C; Jakesz R; Gnant M; Dubsky P; Jesch B; Heinzl H; Birner P
    Breast Cancer Res Treat; 2012 Jul; 134(1):237-44. PubMed ID: 22350732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.
    Statius Muller MG; van Leeuwen PA; de Lange-De Klerk ES; van Diest PJ; Pijpers R; Ferwerda CC; Vuylsteke RJ; Meijer S
    Cancer; 2001 Jun; 91(12):2401-8. PubMed ID: 11413531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.
    Taylor RC; Patel A; Panageas KS; Busam KJ; Brady MS
    J Clin Oncol; 2007 Mar; 25(7):869-75. PubMed ID: 17327608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.
    Murali R; Haydu LE; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Thompson JF; Scolyer RA
    Ann Surg; 2012 Jan; 255(1):128-33. PubMed ID: 21975320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma.
    Han D; Zager JS; Shyr Y; Chen H; Berry LD; Iyengar S; Djulbegovic M; Weber JL; Marzban SS; Sondak VK; Messina JL; Vetto JT; White RL; Pockaj B; Mozzillo N; Charney KJ; Avisar E; Krouse R; Kashani-Sabet M; Leong SP
    J Clin Oncol; 2013 Dec; 31(35):4387-93. PubMed ID: 24190111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact of sentinel lymph node biopsy in patients with thick (>4 mm) melanomas.
    White I; Fortino J; Curti B; Vetto J
    Am J Surg; 2014 May; 207(5):702-7; discussion 707. PubMed ID: 24791630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Podoplanin expression by cancer-associated fibroblasts predicts poor outcome in invasive ductal breast carcinoma.
    Pula B; Jethon A; Piotrowska A; Gomulkiewicz A; Owczarek T; Calik J; Wojnar A; Witkiewicz W; Rys J; Ugorski M; Dziegiel P; Podhorska-Okolow M
    Histopathology; 2011 Dec; 59(6):1249-60. PubMed ID: 22175904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diversity of stage III melanoma in the era of sentinel lymph node biopsy.
    Egger ME; Callender GG; McMasters KM; Ross MI; Martin RC; Edwards MJ; Urist MM; Noyes RD; Sussman JJ; Reintgen DS; Stromberg AJ; Scoggins CR
    Ann Surg Oncol; 2013 Mar; 20(3):956-63. PubMed ID: 23064795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma?
    Gajdos C; Griffith KA; Wong SL; Johnson TM; Chang AE; Cimmino VM; Lowe L; Bradford CR; Rees RS; Sabel MS
    Cancer; 2009 Dec; 115(24):5752-60. PubMed ID: 19827151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
    Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L
    Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metallothionein-overexpression as a prognostic marker in melanoma.
    Weinlich G
    G Ital Dermatol Venereol; 2009 Feb; 144(1):27-38. PubMed ID: 19218909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micrometastasis of a sentinel lymph node in cutaneous melanoma is a significant prognostic factor for disease-free survival, distant-metastasis-free survival, and overall survival.
    Moehrle M; Schippert W; Rassner G; Garbe C; Breuninger H
    Dermatol Surg; 2004 Oct; 30(10):1319-28. PubMed ID: 15458529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraocular tumor-associated lymphangiogenesis a novel prognostic factor for ciliary body melanomas with extraocular extension?
    Heindl LM; Hofmann TN; Adler W; Knorr HL; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
    Ophthalmology; 2010 Feb; 117(2):334-42. PubMed ID: 19892405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.